Cannabis adulterated with the synthetic cannabinoid receptor agonist MDMB-4en-PINACA and the role of European drug checking services.
International Journal of Drug Policy February 2022 Pieter E Oomen, Dominique Schori, Karsten Tögel-Lins et al.
European drug checking services exchange information on drug trends within the Trans European Drug Information (TEDI) network, allowing monitoring and coordination of responses. Starting in Spring 2020, several services detected the synthetic cannabinoid receptor agonist MDMB-4en-PINACA in adulterated low-THC cannabis products. Cannabis products suspected of adulteration were analyzed for the...
DOI: 10.1016/j.drugpo.2021.103493 (opens in new tab)
Full text (opens in new tab)
Cannabis
Adulteration
Drug checking
Mdmb-4en-pinaca
+1